i Fachet József: Genetická regulácia imunitných odpovedí a ich modulácia polysacharidmi:
imunoterapeutické a imuno-biotechnologické vzťahy nádorov; Debrecen, 1993. MTA, Tézy doktorandskej dizertácie
ii viď. posl. str.
iii Fachet et al.: Modulation of immune responses and defense against tumor by a polymannanpolyglycan
polysaccharide; Mannozym; Int.J.Immunopharmacol. 1980; 2, 185.
iv Lapis, K. et al.: Experimental metastasis inhibition by pretreatment of the host; In: Arch
Geschwulstforsch., 1990; 60(2): 97-102.
v Ladanyi, A., Timar, J., Lapis, K.: Effect of lentinan on macrophage cytotoxicity against metastatic
tumor cells; In: Cancer Immunol Immunother, 1993; 36(2): 123-6.
vi Zákány, J. et al.: Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts; Int.
J. Cancer; 1980, 25, 371-376.
vii Suga et al.: Effect of lentinan against allogeneic, syngeneic and autologous primary tumours and its
prophylactic effect on chemical carcinogenesis; In: Manipulation of Host defence Mechanism III. Eds.
Aoki et al.: Excepta Medica; 1985, 116-128.
viii Fachet,J: Effects of mannozym, a polyglucan-polymannan, on different immune responses and
resistanse to tumor; In: Adv. in Immunopharmacology. Ed. By Hadden et al. Pergamon Press, 1981.
483.
ix Fachet, J: A szervezet endokrin és immunvédekező rendszerei; Orvostudomány, 1982, 33, 261-274.
x Zákány, J. et al: Mechanism of the AIPh.MCS1 tumor graft rejection in syngeneic mice; Gann. 1983,
74, 712-722
xi Suga et al.: Effect of lentinan against allogeneic, syngeneic and autologous primary tumours and its
prophylactic effect on chemical carcinogenesis; In: Manipulation of Host defence Mechanism III. Eds.
Aoki at al.: Excepta Medica; 1985, 116-128.
xii Fachet József: Immunválaszok genetikai szabályozása és modulációja polysaccharidákkal: Tumor
immunotherápiás és immun-biotechnológiai vonatkozások; Debrecen, 1993. MTA, Doktori Értekezés
Tézisei
xiii uo.
xiv Sipka, S. et al.: Effect of lentinan on the chemiluminescence produced by human neutrophils and
the murine macrophage cell line C4M?; Int.J. Immunopharmacol., 1985,7, 747-751.
xv Ábel Gy.et al: Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by
mouse peritoneal macrophages: A flow cytometric study; Int.J.Immunopharmacology; 1989, 11, 615-
621.
xvi Ábel Gy.et al.: Effect of lentinan on pinocytosis in mouse peritoneal macrophages and the murine
macrophage cell line C4MI in vitro; Int.J.Immunopharmac,1986, 8, 919-924.
xvii Kerékgyártó, Cs.et al.: Strain differences in the cytotoxic activity and TNF production of murine
macrophages stimulated by lentinan; Int.J.Immunopharmacology, 1996, 18, 347-353.
xviii Fachet,J.et al.: Potentiation of non-specific host defense by polysaccharides like lentinan: possible
mechanism; Int.J.Immunotherapy, 1989, 5, 167-176.
xix Fachet, J. et al: Polysaccharidák immunmodulációs hatásai , daganatellenes alkalmazása és
hatásmechanizmusa; TAIM Nemzetközi Alapítvány IV. Tudományos Konferenciája, 1997, 102-113.
xx Fachet,J.et al.: Potentiation of non-specific host defense by polysaccharides like lentinan: possible
mechanism; Int.J.Immunotherapy, 1989, 5, 167-176.
xxi Fachet, J. et al: Polysaccharidák immunmodulációs hatásai , daganatellenes alkalmazása és
hatásmechanizmusa; TAIM Nemzetközi Alapítvány IV. Tudományos Konferenciája, 1997, 102-113.
xxii Fachet et al.: Effect of lentinan on different types of immune responses including anaphylactic
shock; In: „Host defense mechanisms against cancer”, Proc. of 7th Symp. on host defense
mechanism against cancer, Hakone, Japan, 1985. nov. 8-10. Excerpta Medica; 1986, 183-194.
xxiii Zákány, J. et al.: Effect of lentinan on the production of migration inhibitory factor (MIF) induced
by syngeneic tumor in mice; Int. J. Cancer, 1980, 26, 783-788.
xxiv Kerékgyártó, Cs.et al.: Strain differences in the cytotoxic activity and TNF production of murine
macrophages stimulated by lentinan; Int.J.Immunopharmacology, 1996, 18, 347-353.
xxv Fachet,J.et al.: Potentiation of non-specific host defense by polysaccharides like lentinan: possible
mechanism; Int.J.Immunotherapy, 1989, 5, 167-176.
xxvi Fachet, J. et al: Polysaccharidák immunmodulációs hatásai , daganatellenes alkalmazása és
hatásmechanizmusa; TAIM Nemzetközi Alapítvány IV. Tudományos Konferenciája, 1997, 102-113.
xxvii Fachet József: Immunválaszok genetikai szabályozása és modulációja polysaccharidákkal: Tumor
immunotherápiás és immun-biotechnológiai vonatkozások; Debrecen, 1993. MTA, Doktori Értekezés
Tézisei
xxviii Kodama, N.et al.: Administration of a polysaccharide from Grifola frondosa stimulates immune
function of normal mice; In:J Med Food, 2004, 7(2):141-5.
xxix el-Mekkawy, S. et al.: Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum;
In:Phytochemistry, 1998, 49(6):1651-7.
xxx Min, BS. et al.: Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity
against HIV-1 protease; In: Chem Pharm Bull (Tokyo), 1998, 46(10):1607-12.
x xxi Szakirodalmi adatokat a tumorellenes hatás tekintetében lásd később a részletes összefoglalókban.
xxxii Bernardshaw, S. et al.: An extract f the mushroom Agaricus blazei Murill administered orally
protects against systemic Streptococcus pneumoniae infection in mice; In: Scand J Immunol. 2005,
62(4): 393-8.
xxxiii Eo, SK. et al.: Antiviral activities of various water and methanol soluble substances isolated from
Ganoderma lucidum; In: J. Ethnopharmacol. 1999, 68(1-3): 129-136.
xxxiv Horio, H. et al.: Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic
rats; In: J Nutr Sci Vitaminol (Tokyo), 2001, 47(1): 57-63.
xxxv Kubo, K. et al.: Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake).I.; In:
Biol Pharm Bull, 1994, 17(8):1106-10.
xxxvi Kim, YW. et al.: Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed
oligosaccharides from Agaricus blazei; In: Biotechnol Lett., 2005, 27(7): 483-7.
xxxvii Hikino, H. et al.: Mechanism of hypoglycemic activity of ganoderan B: a glycan of Ganoderma
lucidum fruit bodies; In: Panta Med., 1989, 55(5):423-8.
xxxviii Zhang, H. et al.: Hypoglycemic effect of Ganoderma lucidum polysaccharides; In: Acta Pharmacol
Sin, 2004, 25(2): 191-195.
xxxix Zhang, HN. et al.: In vitro and in vivo protective effect of Ganoderma lucidum polyaccharides on
alloxan-induced pancreatic islets damage; In: Life Sci. 2003, 73(18):2307-19.
xl Lee, SY. et al.: Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of
sympathetic outflow as a mechanism of its hypotensive action; In: Chem Pharm Bull (Tokyo).,1990,
38(5): 1359-64.
xli Kabir, Y. et al.: Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on
blood pressure and plasma lipids of spontaneously hypertensive rats; In: J Nutr Sci Vitaminol (Tokyo),
1987, 33(5): 341-6.
xlii Tasaka, K. et al.: Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The
inhibitory effect of cyclooctasulfur on histamine release; In: Agent Actions, 1988, 23(3-4):157-60.
xlii i Ber ger, A.et al.: Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in
hamsters and minipigs; In: Lipids Health Dis., 2004,18;3:2.
xliv Kim, YW. et al.: Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed
oligosaccharides from Agaricus blazei; In: Biotechnol Lett., 2005, 27(7): 483-7.
xlv Komoda, Y. et al.: Ganoderic acid and its derivatives as cholesterol synthesis inhibitors; In: Chem
Pharm Bull (Tokyo)., 1989, 37(2): 531-3.
xlvi Fukushima, M. et al.: Cholesterol-Lowering Effects of Maitake…In: Exp Biol Med., 2001, 226(8):
758-765.
xlvii Hajjaj, H. et al.: Effect of 26-Oxygenosterols from Ganoderma lucidum and Their Activity as
Cholesterol Synthesis Inhibitors; In: Applied and Enviromental Microbiology, 2005, July, p. 3653-3658.
xlviii Kubo, K. et al.: Anti-hyperliposis effect of maitake fruit body (Grifola frondosa).I.; In: Biol Pharm
Bull., 1997, 20(7): 781-5.
xlix Kabir, Y. et al.: Effect of shiitake (Lentinus edodes) and maitake (Grifola frondosa) mushrooms on
blood pressure and plasma lipids of spontaneously hypertensive rats; In: J Nutr Sci Vitaminol (Tokyo),
1987, 33(5): 341-6.
l Ren, LK. et al.: Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental
investigation); In: Vopr Pitan, 1989,(1):16-9.
li Kim, YW. et al.: Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed
oligosaccharides from Agaricus blazei; In: Biotechnol Lett., 2005, 27(7): 483-7.
lii Tao, J. et al.: Experimental and clinical studies on inhibitory effect of ganoderma lucidum on platelet
aggregation; In: J Tongji Med Univ, 1990, 10(4): 240-3.
liii Lin, H. et al.: Maitake beta-glucan MD-fraction enhances bone marrow colony formation and
reduces doxorubicin toxicity in vitro; In: Int Immunopharmacol., 2004, 4(1): 91-9.
liv uo.
lv Zhu, WW. et al.: Effect of the oil from ganoderma lucidum spores on pathological changes in the
substantia nigra and behaviors of MPTP-treated mice; In: Di Yi Jun Da Xue Xue Bao, 2005, 25(6):667-
71.
lvi Tang, W. et al: A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum
polysaccharide extract in neurasthenia; In: J. Med Food, 2005, 8(1):53-8.
lvii Shieh, YH. et al.: Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in
mice; In: Am J Chin Med., 2001, 29 (3-4): 501-7.
l viii Li, Y. et al.: Anti-hepatitis Activities in the Broth of Ganoderma lucidum…; In:Am J Chin Med., 2006,
34(2): 341-9.
lix Yang, XJ. et al.: In vitro and in vivo protective effects of proteoglycan isolated from mycelia of
Ganoderma lucidum on carbon tetrachloride-induced liver injury; In: World J Gastroenterol., 2006,
12(9):1379-85.
lx Zhang, GL. et al.: Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG- induced
immune liver injury in mice; In: World J Gastroenterol., 2002, 8(4): 728-33.
lxi Lin, JM. et al.: Radical scavenger and antihepatotoxic activity of Ganoderma…; In: J
Ethnopharmacol. 1995, 47(1): 33-41.
lxii Lin, WC. et al.: Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver
fibrosis in rats; In: Gastroenterol., 2006, 12(2): 265-270.
lxiii Kodama, N. et al: Administration of a polysaccharide from Grifola frondosa stimulates immune
function of normal mice. In:J Med Food 2004 Summer;7(2):141-5.
lxiv Kodama, N. et al.: Effects of D-Fraction…In: Biol Pharm Bull 2002 Dec;25(12):1647-50
lxv Kodama, N. et al.:Enhancement of cytotoxicity of NK cells by D-Fraction…In:Oncol Rep 2005
Mar;13(3):497-502
lxvi Kodama, N. et al.:Effect of Maitake (Grifola frondosa) D-Fraction on activation of NK cells in cancer
patients In:J Med Food 2003 Winter;6(4):371-7.
lxvii Jiang, J. et al..: Ganoderma lucidum suppresses growth of breast cancer cells, In:Nutr Cancer
2004;49(2):209-216.
lxviii Jiang, J. et al.: Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate
cancer cells PC-3, In: Int J Oncol 2004 May;14(5):1093-9.
lxix Lu, QY.et al.: Ganoderma lucidum extracts inhibit growth and induce actin polymerization in
bladder cancer cells in vitro, In: Cancer Lett 2004 Dec 8;216(1):9-20.
lxx Stanley, G. et al.: Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion
of VEGF and TGF-beta1 from prostate cancer cells; In:Biochem Biophys Res Commun, 2005,
330(1):46-52.
lxxi Muller, CI. et al.: Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple
myeloma cells; In: Leuk Res. 2006 jan. 16.
lxxii Cao, QZ. et al.: Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular
endothelial cell and the induction of VEGF in human lung cancer cell; In: Life Sci. 2006, 78(13): 1457-
63.
lxxiii Kimura, Y. et al.: Antitumor and antimetastatic effects on liver of triterpenoid fractions of
Ganoderma lucidum:… In:Anticancer Res 2002 Nov-Dec;22(6A):3309-18.
lxxiv Lu, H .et al.: A water-soluble extract from cultured medium of Ganoderma lucidum (Reishi)
mycelia suppresses azoxymethane –induction of colon cancers in male F344 rats, In:Oncol Rep 2003
Mar-Apr;10(2):375-9
lxxv Gao, Y.et al.: Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune
functions in advanced-stage cancer patients, In: Immunol Invest 2003 Aug;32(3):201-15
lxxvi Nakajima, A. et al.: Effect of hot water extract from Agaricus blazei Murill on antibody-producing
cells in mice, In: Int Immunopharmacol 2002 Jul;2(8):1205-11.
lxx vii Lee YL: Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma 180
inoculation model, In: Exp Anim 2003 Oct;52(5):371-5.
lxxviii Kaneno, R. et al: Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK
activity…In: Food Chem Toxicol 2004 Jun;42(6):909-16.
lxxix Kobayashi, H. et al.: Suppressing effects of daily oral supplementation of beta-glucan extracted
from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model;
In: J Cancer Res Clin Oncol., 2005, 131(8): 527-38.
lxxx Kubo N. et al.: Protective effects of a water-soluble extract…In: Int J Mol Med 2005
Mar;15(3):401-6.
lxxxi Ahn, WS. et al.: Natural killer cell activity and quality of life were improved by consumption of a
mushroom extract…In:Int J Gynecol Cancer 2004 Jul-Aug;14(4):589-94.
lxxxii Lelley, J.: Die Heilkraft der Pilze, 2003, Ulm.
lxxxiii Ley, M. Beth: Agaricus Blazei Murill, 2001, BL Publications.